Granulocyte macrophage-colony stimulating factor augmentation therapy in sepsis: Is there a role?

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 2, 2002, Pages 129-130

  Trapnell, Bruce C ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC THERAPY; EDITORIAL; IMMUNOPHENOTYPING; INCIDENCE; INFECTION; LUNG GAS EXCHANGE; MORTALITY; PRIORITY JOURNAL; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNITED STATES;

GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; NEUTROPHILS; PULMONARY GAS EXCHANGE; SEPSIS;

EID: 0037099372     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2205017     Document Type: Editorial

References (12)

1. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
2. The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study
3. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
4. Treating patients with severe sepsis
5. Pathogenetic mechanisms of septic shock
6. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
7. Dysregulation of in vitro cytokine production by monocytes during sepsis
8. GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense
9. Granulocyte-macrophage colony-stimulating factor induces activation and restores respiratory burst activity in monocytes from septic patients
10. A randomized phase II trial granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction
11. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: Relation to disease severity, multiple organ dysfunction, and mortality
12. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia